Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562
142047-97-0
17640-26-5
17639-73-5
110-99-6
120289-22-7
817-95-8
233691-67-3 | Boc-lys(ac)-amc | AA002MWL | MFCD02683946
234442-58-1 | Fmoc-n-(butyl)-glycine | AA002N6F | MFCD08457838
2353-33-5 | 4-amino-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2-dihydro-1,3,5-triazin-2-one | AA002NJ1 | MFCD00043011
236406-39-6 | tert-Butyl 2,8-diazaspiro[4.5]decane-8-carboxylate | AA002NWR | MFCD09608078
23702-54-7 | Diveratryl ether | AA002O4M | MFCD00025741
245539-10-0 | 1,4-Dichloro-2-isocyano-benzene | AA002OFV | MFCD02664598
24636-31-5 | 2-Propenoic acid, 2-methyl-, 3-(chlorodimethylsilyl)propyl ester | AA002OSV | MFCD00053899
247186-56-7 | tert-Butyl 3-formylbenzoate | AA002P3N | MFCD02180885
2479-46-1 | 1,3-Bis(4-aminophenoxy)benzene | AA002PCY | MFCD00039154
248920-11-8 | 2-(2-Bromo-3-methylphenyl)acetic acid | AA002POL | MFCD18392219